Меню
Набор скоро начнётся NCT07644130

Bergen Four-Day Treatment (B4DT) for Obsessive-Compulsive Disorder

Без фазы С лечением Obsessive Compulsive Disorder (OCD)

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Bergen Four-Day Treatment (B4DT).
Кому может быть актуально
Состояния в реестре: Obsessive Compulsive Disorder (OCD). Базовые параметры: от 18 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Финляндия
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Обзор

The aim of this study is to expand access to Bergen Four-Day Treatment (B4DT) in Finland and to integrate it into psychiatric care pathways at Tampere University Hospital (TAYS). A Bergen team has been established within TAYS Psychiatry and has been trained in collaboration with the B4DT team from HUS and the Norwegian developers. The objective of this study is to enhance understanding of the model's adaptability to the Finnish healthcare system, evaluate healthcare professionals' attitudes toward the intervention, and assess treatment outcomes. The aim is to recruit approximately 35 patients for the study. Patients will be recruited from a minimum of three groups (15 patients) and up to a maximum of six groups (35 patients). The criteria for admission to B4DT and for participation in the study are identical. The treatment and the study may include patients receiving specialized psychiatric care at Tampere University Hospital who have been diagnosed with obsessive-compulsive disorder and who experience significant impairment due to their symptoms. In addition, personnel from TAYS Psychiatry who recommend and refer patients for B4DT will be recruited for the study. The estimated number of participating staff members is approximately 30.

Вмешательства

  • Другое Bergen Four-Day Treatment (B4DT)
    The intervention starts with a pre-assessment, during which patients' motivation, expectations, and willingness to engage in exposure practice are assessed. After the pre-assessment, patients participate in a four-day intensive treatment period based on exposure and response prevention. The intensive phase is an individualized intervention delivered within a group framework. This phase is followed by a three-month period of independent practice, with a couple of appointments with the therapist.

Первичные конечные точки

  • Yale-Brown Obsessive-Compulsive Scale, Self-Report (Y-BOCS-SR) [Срок оценки: From pre-assessment to the end of follow-up approximately four to six months.]
  • Obsessive-Compulsive Inventory - Revised (OCI-R) [Срок оценки: From pre-assessment to the end of follow-up approximately four to six months.]
  • Client Satisfaction Questionnaire (CSQ-8) [Срок оценки: From pre-assessment to the end of follow-up approximately four to six months.]
  • Credibility and Expectancy Questionnaire (CEQ) [Срок оценки: approximately four months]
  • Self-report for healthcare professionals (AIM, IAM, FIM) [Срок оценки: approximately four months]
Вторичные конечные точки (5)
  • Patient Health Questionnaire (PHQ-9) [Срок оценки: From pre-assessment to the end of follow-up approximately four to six months.]
  • Generalized Anxiety Disorder Scale (GAD-7) [Срок оценки: From pre-assessment to the end of follow-up approximately four to six months.]
  • Work and Social Adjustment Scale (WSAS) [Срок оценки: From pre-assessment to the end of follow-up approximately four to six months]
  • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS) [Срок оценки: From pre-assessment to the end of follow-up approximately four to six months.]
  • EuroQol 5-Dimension Questionnaire (EQ-5D) [Срок оценки: From pre-assessment to the end of follow-up approximately four to six months.]

Критерии участия

Критерии включения

  • diagnosed with obsessive-compulsive disorder
  • willingness to participate in exposure-based treatment

Критерии исключения

  • intellectual disability
  • autism spectrum disorder that precludes engagement in psychotherapeutic work
  • a psychotic disorder with current psychotic symptoms
  • underweight or very rapid weight loss affecting cognition
  • severe suicidality
  • substance dependence
  • benzodiazepine medication (use of Z-drugs as sleep medication is permitted)
  • In addition, ongoing psychotherapy may prevent participating in the B4DT.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Не применимо
Модель
Одна группа
Маскирование
Открытое
Основная цель
Лечение

Центры проведения

Финляндия · 1 центр
  • Tampere University Hospital — Tampere

Идентификаторы

NCT: NCT07644130 · R26017

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗